Asthika Goonewardene
Stock Analyst at Truist Securities
(2.10)
# 2,890
Out of 5,090 analysts
96
Total ratings
38.46%
Success rate
-3.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Initiates: Buy | $43 | $24.69 | +74.16% | 1 | Nov 25, 2025 | |
| MRSN Mersana Therapeutics | Downgrades: Hold | $36 → $31 | $27.78 | +10.71% | 6 | Nov 13, 2025 | |
| GMAB Genmab | Reiterates: Buy | $49 → $48 | $31.74 | +51.23% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $127 → $145 | $121.22 | +19.62% | 3 | Nov 3, 2025 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $25.45 | +53.24% | 2 | Oct 7, 2025 | |
| MRUS Merus | Downgrades: Hold | $88 → $97 | $96.14 | +0.89% | 3 | Sep 29, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $16.51 | +505.69% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $79.64 | +24.31% | 1 | Sep 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $44.36 | +10.46% | 11 | Jul 29, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $96.25 | +61.04% | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $71 | $28.13 | +152.40% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $1.43 | +599.30% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.55 | +545.16% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.20 | +581.82% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.31 | +91.15% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $69.56 | +95.51% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $150 | $8.66 | +1,632.10% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.51 | +164.90% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.90 | +900.00% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.53 | +4,954.29% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $10.92 | +998.90% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.98 | +2,930.30% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $12.34 | +1,359.26% | 4 | Aug 23, 2022 |
ArriVent BioPharma
Nov 25, 2025
Initiates: Buy
Price Target: $43
Current: $24.69
Upside: +74.16%
Mersana Therapeutics
Nov 13, 2025
Downgrades: Hold
Price Target: $36 → $31
Current: $27.78
Upside: +10.71%
Genmab
Nov 7, 2025
Reiterates: Buy
Price Target: $49 → $48
Current: $31.74
Upside: +51.23%
Gilead Sciences
Nov 3, 2025
Reiterates: Buy
Price Target: $127 → $145
Current: $121.22
Upside: +19.62%
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $25.45
Upside: +53.24%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $88 → $97
Current: $96.14
Upside: +0.89%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $16.51
Upside: +505.69%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $79.64
Upside: +24.31%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $44.36
Upside: +10.46%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $96.25
Upside: +61.04%
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $28.13
Upside: +152.40%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.43
Upside: +599.30%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.55
Upside: +545.16%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.20
Upside: +581.82%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $18.31
Upside: +91.15%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $69.56
Upside: +95.51%
Aug 16, 2024
Maintains: Buy
Price Target: $180 → $150
Current: $8.66
Upside: +1,632.10%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.51
Upside: +164.90%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.90
Upside: +900.00%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.53
Upside: +4,954.29%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $10.92
Upside: +998.90%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.98
Upside: +2,930.30%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $12.34
Upside: +1,359.26%